Key details
Phase
Post-approval monitoring
Sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Collaborators
Centers for Disease Control and Prevention, China
Enrollment target
~1,500 participants
Primary completion
March 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
6 Months – 35 Months
Last updated January 2024